# H5-VLP + GLA-AF Vaccine Trial in Healthy Adult Volunteers

> **NCT01657929** · PHASE1 · COMPLETED · sponsor: **Access to Advanced Health Institute (AAHI)** · enrollment: 105 (actual)

## Conditions studied

- Influenza A Subtype H5N1 Infection

## Interventions

- **BIOLOGICAL:** H5-VLP + GLA-AF
- **BIOLOGICAL:** H5-VLP alone
- **BIOLOGICAL:** H5-VLP + Alhydrogel(R)
- **BIOLOGICAL:** Licensed H5N1 vaccine

## Key facts

- **NCT ID:** NCT01657929
- **Lead sponsor:** Access to Advanced Health Institute (AAHI)
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2014-02-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01657929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01657929, "H5-VLP + GLA-AF Vaccine Trial in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01657929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*